Process View
A necrotic cell death process that results from the activation of endogenous cellular processes, such as signaling involving death domain receptors or Toll-like receptors.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "programmed necrotic cell death"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | Mouse | |
| BIRC3 | baculoviral IAP repeat containing 3 | 1.000 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 1.000 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 1.000 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.994 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.994 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.993 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.993 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.985 | Human | |
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.981 | Human | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.974 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.968 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.935 | Human | |
| TRAF2 | TNF receptor-associated factor 2 | 0.922 | Mouse | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.878 | Human | |
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.703 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.614 | Human | |
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.599 | ||
| TBK1 | TANK-binding kinase 1 | 0.539 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.493 | ||
| TANK | TRAF family member-associated NFKB activator | 0.472 | ||
| RNF31 | ring finger protein 31 | 0.461 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.385 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.307 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.292 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.285 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.277 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.255 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.192 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.175 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.150 | ||
| BID | BH3 interacting domain death agonist | 0.148 | ||
| TNF | tumor necrosis factor | 0.146 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.120 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.117 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.113 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.108 | ||
| SMCR7 | Smith-Magenis syndrome chromosome region, candidate 7 | 0.108 | ||
| DAXX | death-domain associated protein | 0.105 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.098 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.092 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.090 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.088 | Mouse | |
| HDAC6 | histone deacetylase 6 | 0.079 | ||
| SLC25A3 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 | 0.079 | ||
| CDC14B | CDC14 cell division cycle 14 homolog B (S. cerevisiae) | 0.076 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.073 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.072 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.068 | ||
| RNF144B | ring finger protein 144B | 0.060 | ||
| TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.053 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.050 | Human | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.050 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.050 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.045 | ||
| THOC3 | THO complex 3 | 0.037 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.036 | ||
| EEF2 | eukaryotic translation elongation factor 2 | 0.034 | ||
| SHARPIN | SHANK-associated RH domain interactor | 0.032 | ||
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.030 | ||
| FBXO33 | F-box protein 33 | 0.030 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.029 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.028 | ||
| TRIM21 | tripartite motif containing 21 | 0.028 | ||
| PPP6C | protein phosphatase 6, catalytic subunit | 0.026 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.026 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.024 | ||
| GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.024 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.024 | ||
| MYH10 | myosin, heavy chain 10, non-muscle | 0.023 | ||
| TRIM38 | tripartite motif containing 38 | 0.023 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.023 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.023 | ||
| MYH14 | myosin, heavy chain 14, non-muscle | 0.023 | ||
| PYCARD | PYD and CARD domain containing | 0.021 | ||
| LMO4 | LIM domain only 4 | 0.020 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.020 | ||
| HSPA1L | heat shock 70kDa protein 1-like | 0.020 | ||
| BECN1 | beclin 1, autophagy related | 0.019 | ||
| TKT | transketolase | 0.019 | ||
| KIAA1377 | KIAA1377 | 0.019 | ||
| TRIM25 | tripartite motif containing 25 | 0.018 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.018 | Mouse | |
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.017 | ||
| EIF4A1 | eukaryotic translation initiation factor 4A1 | 0.017 | ||
| YBX1 | Y box binding protein 1 | 0.016 | Human | |
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | 0.016 | Human | |
| PABPC4 | poly(A) binding protein, cytoplasmic 4 (inducible form) | 0.015 | ||
| ARRB2 | arrestin, beta 2 | 0.015 | ||
| NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.015 | ||
| RNR2 | l-rRNA | 0.015 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.015 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.014 | Mouse | |
| TUBA3C | tubulin, alpha 3c | 0.014 | ||
| RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.014 | ||
| PITPNA | phosphatidylinositol transfer protein, alpha | 0.014 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.014 | ||
| NLK | nemo-like kinase | 0.014 | ||
| FKBP5 | FK506 binding protein 5 | 0.014 | ||
| OXA1L | oxidase (cytochrome c) assembly 1-like | 0.013 | ||
| JAK2 | Janus kinase 2 | 0.013 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.013 | ||
| RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.013 | Human | |
| MIB1 | mindbomb homolog 1 (Drosophila) | 0.013 | ||
| SMCR7L | Smith-Magenis syndrome chromosome region, candidate 7-like | 0.012 | ||
| RNF19A | ring finger protein 19A | 0.012 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.012 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.012 | ||
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.011 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | Mouse | |
| ERP29 | endoplasmic reticulum protein 29 | 0.011 | ||
| ATM | ataxia telangiectasia mutated | 0.011 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.010 | ||
| FOXO1 | forkhead box O1 | 0.010 | ||
| TMOD3 | tropomodulin 3 (ubiquitous) | 0.010 | ||
| HSPA9 | heat shock 70kDa protein 9 (mortalin) | 0.010 | ||
| GRIP1 | glutamate receptor interacting protein 1 | 0.010 |